Early Drug Discovery and Development of Novel Cancer Therapeutics Targeting DNA Polymerase Eta (POLH)
Polymerase eta (or Pol η or POLH) is a specialized DNA polymerase that is able to bypass certain blocking lesions, such as those generated by ultraviolet radiation (UVR) or cisplatin, and is deployed to replication foci for translesion synthesis as part of the DNA damage response (DDR). Inherited de...
Guardado en:
Autores principales: | David M. Wilson, Matthew A. J. Duncton, Caleb Chang, Christie Lee Luo, Taxiarchis M. Georgiadis, Patricia Pellicena, Ashley M. Deacon, Yang Gao, Debanu Das |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40bb23ee3ada4b41a46d7f5aa6c07ebc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DockStream: a docking wrapper to enhance de novo molecular design
por: Jeff Guo, et al.
Publicado: (2021) - Drug discoveries & therapeutics
-
Novel Antimicrobials from Uncultured Bacteria Acting against <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
por: Jeffrey Quigley, et al.
Publicado: (2020) -
Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
por: José Manuel Ezquerra-Aznárez, et al.
Publicado: (2021) -
Radioligands Targeting Fibroblast Activation Protein (FAP)
por: Thomas Lindner, et al.
Publicado: (2021)